Funded Biotechnology Startups in United States
15 funded biotechnology startups in united states — recent funding rounds, disclosed amounts, and headquarters. Updated weekly, free to browse.
The 15 most recent U.S. biotechnology and healthcare funding rounds in this view span late September through mid-November 2025, with 12 of those closing in October or November alone. Series A deals account for four rounds, headlined by Expedition Therapeutics' $165M raise and NILO Therapeutics' $101M close — both recorded on October 8 in San Francisco and New York respectively. Seed rounds make up the largest share at six deals, ranging from $200K for AccufyDx in Rockville to $12M for Modulight Bio in Boston.
Geographic spread runs well beyond the traditional coastal hubs. Funded companies here include Gut Brain Axis Therapeutics in Tempe, iOrganBio in Chapel Hill, Gregor Diagnostics in Madison, and Leukogene Therapeutics in Mount Pleasant, alongside Rion Vet in Rochester — the most recently dated deal at a $15M Series A on November 16. Four rounds carry undisclosed amounts, including Azure Biosystems, Oral Biolife, and Real Diagnostics, with the remainder ranging from $240K to $165M.
Most recent rounds
15 shownRelated listings
Frequently asked
What are the largest disclosed rounds among these companies?
Expedition Therapeutics (San Francisco) leads at $165M in a Series A closed October 8, 2025, followed by NILO Therapeutics (New York) at $101M in a Series A the same day. Predicta Biosciences in Boston comes next at $23M, also a Series A, closed September 30.
How are funding stages distributed across these 15 companies?
Seed rounds account for six of the 15 deals, Series A for four, and 'Venture - Series Unknown' for four others. Real Diagnostics in Reisterstown is the one private equity-backed company in this set.
How many rounds have undisclosed amounts, and which companies are they?
Four rounds list no public deal size: Azure Biosystems (Dublin), Leukogene Therapeutics (Mount Pleasant), Oral Biolife (Bethlehem), and Real Diagnostics (Reisterstown). The smallest disclosed figure across all 15 rounds is $200K from AccufyDx in Rockville.
How geographically spread is biotech funding activity in this data?
Boston is the only city appearing more than once, with Modulight Bio ($12M Seed) and Predicta Biosciences ($23M Series A) both based there. The remaining 13 companies are each in distinct cities, spanning Rochester, Tempe, Chapel Hill, Madison, Philadelphia, North Miami Beach, and several smaller markets.
Which companies closed rounds most recently in this view?
Seven of the 15 rounds closed in November 2025. Rion Vet (Rochester, $15M Series A, November 16) is the latest on record, followed by Modulight Bio and Nomax Therapeutics (both November 12), and Azure Biosystems and Leukogene Therapeutics (both November 10).
How many therapeutics-named companies appear here, and at what stages did they raise?
Five companies carry 'Therapeutics' in their name. Nomax Therapeutics (North Miami Beach, $1M) and Gut Brain Axis Therapeutics (Tempe, $2M) raised seed rounds. Expedition Therapeutics (San Francisco, $165M) and NILO Therapeutics (New York, $101M) closed Series A rounds. Leukogene Therapeutics (Mount Pleasant) raised a venture round with an undisclosed amount.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.